Benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy

Journal of Contemporary Brachytherapy

Volumn 4, Issue 3, 2012, Pages 141-145

  Kaljouw, Emmie ^a   Pieters, Bradley ^a   Koedooder, Kees ^a   Lucas, Cees ^a   Koning, Caro ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Brachytherapy; Computer assisted radiotherapy planning; D 90; Prostatic neoplasms; Transrectal ultrasound; V 100

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; BRACHYTHERAPY IMPLANT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOGRAM; HUMAN; MALE; PROSTATE; PROSTATE CANCER; RADIATION DOSE; TRANSDUCER; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT PLANNING;

EID: 84867908619     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2012.30680     Document Type: Article

References (12)

1. Polo A, Salembier C, Venselaar J et al. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radioth Oncol 2010; 94: 12-23.
2. Ali I, Algan O, Thompson S et al. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy. Phys Med Biol 2009; 54: 5595-5611.
3. Acher P, Puttagunta S, Rhode K et al. An analysis of intraoperative versus post-operative dosimetry with CT, CT-MRI fusion and XMR for the evaluation of permanent prostate brachytherapy implants. Radioth Oncol 2010; 96: 166-171.
4. Kaplan I, Meskell P, Oldenburg N et al. Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer. Brachytherapy 2006; 5: 147-151. (Pubitemid 44080700)
5. Igidbashian L, Donath D, Carrier J-F et al. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy. Int J Radiat Oncol Biol Phys 2008; 72: 605-609.
6. Moerland MA, van Deursen MJH, Elias SG et al. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: Comparison between loose and stranded seed implants. Radioth Oncol 2009; 91: 202-206.
7. 125I seed implantation. Int J Radiat Oncol Biol Phys 2004; 58: 292-299.
8. Yu Y, Anderson L, Li Z et al. Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64a. Med Phys 1999; 26: 2054-2076. (Pubitemid 29498659)
9. Chauveinc L, Flam T, Solignac S et al. Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institute Curie/Hospital Cochin (Paris) group. Int J Radiat Oncol Biol Phys 2004; 59: 691-695. (Pubitemid 38748734)
10. Stone N, Hong S, Lo Y-Ch et al. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Brachytherapy 2003; 2: 17-25. (Pubitemid 37329402)
11. Chew M-S, Xue J, Houser C et al. Impact of transrectal ultrasound-and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy. Brachytherapy 2009; 8: 255-264.
12. Ohashi T, Yorozu A, Toya K et al. Comparison of intraoperative ultrasound with postimplant computed tomography - dosimetric values at Day 1 and Day 30 after prostate brachytherapy. Brachytherapy 2007; 6: 246-253. (Pubitemid 350030633)